Please ensure Javascript is enabled for purposes of website accessibility
top of page

Avi Treves PhD   

Short Bio   Feb 2022


Main Expertise:


  • Founder and CEO of publicly traded biotech company (NASDAQ: GMDA)


  • Leading role in successful development of three cell therapy products into clinical trials

  • Hematopoietic stem cells for hematological malignancies (Gamida – Cell)

  • T-Cells for adoptive immune therapy of solid tumors (Sheba Medical Center).

  • Mesenchymal Stem Cells for neuro-degenerative diseases  


  • Translational research, regulatory and clinical development

  • Immuno- oncology

  • Advanced therapies and stem cells technologies, diabetes, and neurological diseases


  • Business development and funding of biotech companies


  • Tech transfer and commercialization of hospitals and academic institutes programs


  • PhD from the Weizmann Institute of Science (Israel) and post doc at Stanford University Medical School (US)




  • Co-author of more than 100 scientific publications and 10 patents.



Current  and past activities:


Active consultant to several biotech companies in the fields of oncology and auto-immune diseases.



Previous experience:


           Cell technologies and tissue engineering for diabetes

  • Head of the Adult Stem Cells Translation Laboratory at the  Sheba Center for Regenerative Medicine, (2009-2015)

  • Co-manager and scientist at the Ella Institute for Treatment and Research of Melanoma, adoptive immunotherapy clinical programs at the Sheba Medical Center (2004-2013)

  • Deputy Director, Sheba Cancer Research Center (2003-2013)

  • Founder and CTO of BioRegenerate Ltd. (2005-2008)

  • Founder, CEO and CTO of Gamida-Cell Ltd. A cell therapy public company (NASDAQ: GMDA) in clinical phase of pipeline of products (1998-2003)

  • Founder and CEO of Hadasit Ltd, the commercialization company of the Hadassah Medical Center (1989-1994)

  • Head, Division of Research and Development, Hadassah Medical Center (1985-1994)

  • The Israeli Ministry of Health Committee for Registering of Cellular

      Based Therapies


For Bio-Pharma Consulting,

Please Contact:                    

bottom of page